Getinge AB (GNGBY)
27.33
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
Getinge Enterprise Value : 7.761B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 7.761B |
| October 28, 2026 | 7.761B |
| October 27, 2026 | 7.632B |
| October 26, 2026 | 7.632B |
| October 23, 2026 | 7.632B |
| October 22, 2026 | 7.555B |
| October 21, 2026 | 7.555B |
| October 20, 2026 | 7.480B |
| October 19, 2026 | 7.480B |
| October 16, 2026 | 7.476B |
| October 15, 2026 | 7.422B |
| October 14, 2026 | 7.299B |
| October 13, 2026 | 7.278B |
| October 12, 2026 | 7.254B |
| October 09, 2026 | 7.250B |
| October 08, 2026 | 7.146B |
| October 07, 2026 | 7.146B |
| October 06, 2026 | 7.194B |
| October 05, 2026 | 7.144B |
| October 02, 2026 | 7.047B |
| October 01, 2026 | 7.039B |
| September 30, 2026 | 7.090B |
| September 29, 2026 | 7.197B |
| September 28, 2026 | 7.368B |
| September 25, 2026 | 7.180B |
| Date | Value |
|---|---|
| September 24, 2026 | 7.152B |
| September 23, 2026 | 7.222B |
| September 22, 2026 | 7.271B |
| September 21, 2026 | 7.152B |
| September 18, 2026 | 7.021B |
| September 17, 2026 | 7.101B |
| September 16, 2026 | 7.101B |
| September 15, 2026 | 7.149B |
| September 14, 2026 | 7.149B |
| September 11, 2026 | 7.063B |
| September 10, 2026 | 7.117B |
| September 09, 2026 | 7.233B |
| September 08, 2026 | 7.271B |
| September 04, 2026 | 7.346B |
| September 03, 2026 | 7.434B |
| September 02, 2026 | 7.345B |
| September 01, 2026 | 7.345B |
| August 31, 2026 | 7.459B |
| August 28, 2026 | 7.459B |
| August 27, 2026 | 7.482B |
| August 26, 2026 | 7.482B |
| August 25, 2026 | 7.482B |
| August 24, 2026 | 7.482B |
| August 21, 2026 | 7.482B |
| August 20, 2026 | 7.497B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xvivo Perfusion AB | 663.60M |
| Paxman AB | 71.82M |
| Enovis Corp. | 2.674B |
| Edwards Lifesciences Corp. | 51.01B |
| Intuitive Surgical, Inc. | 151.60B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 75.22M |
| Revenue (Quarterly) | 875.02M |
| Total Expenses (Quarterly) | 800.43M |
| EPS Diluted (Quarterly) | 0.2735 |
| Gross Profit Margin (Quarterly) | 45.17% |
| Profit Margin (Quarterly) | 8.60% |
| Earnings Yield | 4.04% |
| Operating Earnings Yield | 6.86% |
| Normalized Earnings Yield | 4.245 |